According to the Las Vegas Review-Journal (4/27/14), District Judge Kerry Earley heard arguments from the plaintiffs that Takeda’s lawyers have violated court orders and been disrespectful to the judge. The judge herself reportedly also called Takeda’s attorneys’ actions “very egregious” and “disrespectful.” Furthermore, according to the same report, although the jury did not see all of the contested actions, at one point the judge did have to instruct the jury to disregard one attorney’s comments and gestures.
The plaintiffs allege that Takeda’s lawyers are purposely attempting to cause a mistrial in the litigation.
The plaintiffs in the litigation are 81-year-old Delores Cipriano and 80-year-old Bertha Triana, who have both filed lawsuits alleging their use of Actos resulted in their suffering bladder cancer. Both plaintiffs reportedly underwent multiple surgeries to treat their bladder cancer.
The trial began on March 9. According to the Legal Examiner (5/2/14), the court will tell the jury that it is not to consider the actions of the plaintiffs’ counsel in repeatedly objecting to the defense counsels’ actions when it considers the outcome of the case. The court will instruct the jury that the plaintiffs’ counsel made necessary objections to defense counsel’s “repeated violations” of the court’s orders.
According to a different article by the Las Vegas Review-Journal (4/15/14), Cipriano has testified in the lawsuit and said she was never warned about the risk of bladder cancer and would not have taken the drug had she known about that risk. She was reportedly sent for testing after finding blood in her urine, which was when the bladder cancer diagnosis was made.
Takeda was already sanctioned in a different lawsuit for allegedly destroying or failing to maintain important documents linked to Actos litigation. In that case, the plaintiff was later awarded $9 billion.
READ MORE ACTOS SIDE EFFECTS LEGAL NEWS
Actos was approved in 1999 to be used along with diet and exercise to treat adults with type 2 diabetes. Concerns about a risk of bladder cancer, however, have resulted in lawsuits being filed against Takeda Pharmaceuticals.
Those lawsuits allege patients were not adequately warned about the risks associated with use of Actos.